AA
TMO icon

Altman Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Altman Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,002
Closed -$1.29M – 100
2025
Q1 		$1.29M Buy
3,002
+144
+5% +$78K 0.59% 80
2024
Q4 		$1.49M Buy
2,858
+67
+2% +$36.8K 0.63% 73
2024
Q3 		$1.73M Buy
+2,791
New +$1.65M 0.77% 65
2024
Q2 		– Sell
-2,735
Closed -$1.58M – 94
2024
Q1 		$1.58M Buy
2,735
+339
+14% +$190K 0.77% 61
2023
Q4 		$1.27M Sell
2,396
-220
-8% -$106K 0.67% 71
2023
Q3 		$1.32M Buy
+2,616
New +$1.39M 0.83% 56
2023
Q1 		$1.12M Buy
2,436
+22
+0.9% +$12.4K 1.03% 46
2022
Q4 		$1.41M Sell
2,414
-26
-1% -$13.8K 0.87% 41
2022
Q3 		$1.24M Sell
2,440
-945
-28% -$529K 0.78% 43
2022
Q2 		$1.98M Sell
3,385
-2,143
-39% -$1.18M 1.13% 23
2022
Q1 		$3.27M Sell
5,528
-61
-1% -$35K 1.69% 17
2021
Q4 		$3.24M Sell
5,589
-274
-5% -$171K 1.98% 13
2021
Q3 		$3.71M Sell
5,863
-439
-7% -$241K 2.05% 8
2021
Q2 		$3.41M Buy
6,302
+211
+3% +$99.6K 1.93% 10
2021
Q1 		$2.78M Sell
6,091
-199
-3% -$95K 1.79% 11
2020
Q4 		$2.93M Sell
6,290
-27
-0.4% -$12.7K 1.84% 11
2020
Q3 		$2.79M Buy
6,317
+26
+0.4% +$10.7K 1.98% 12
2020
Q2 		$2.28M Buy
6,291
+186
+3% +$62.3K 1.94% 21
2020
Q1 		$1.73M Buy
+6,105
New +$1.93M 1.61% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Altman Advisors's TMO Position: Q2 2025 in Review

Altman Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 3,002 shares — an estimated $1.29M sold.

Altman Advisors first reported a position in TMO in Q1 2020 and held it in 19 quarters. The position peaked at $3.71M in Q3 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Altman Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Altman Advisors sold 3,002 Thermo Fisher Scientific shares in Q2 2025, an estimated $1.29M.
  • Altman Advisors first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 19 quarters.
  • Altman Advisors's Thermo Fisher Scientific position peaked at $3.71M in Q3 2021.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Altman Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.